Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate topical application of Cocaine HCl 4% and 10% on safety and efficacy in local (topical) anesthesia for diagnostic procedures and surgeries on or through accessible mucous membranes of the nasal cavities.


Clinical Trial Description

Randomized, prospective, multisite, double-blind, placebo-controlled, parallel-group study of a Placebo Topical Solution versus Cocaine HCl 4% or 10% Topical Solution as an anesthetic prior to a diagnostic procedure or surgery.

In the Safety and Efficacy first phase, subjects will be randomized in a 1:1:1 fashion to one of the three treatment groups (placebo, Cocaine HCl 4% or 10% topical solution) pre-procedure and given one application of up to 4 mL from one bottle of the assigned test product. After pre-procedure Von Frey filament testing, the blind will be broken, but only relative to placebo versus cocaine, not relative to the strength of the cocaine. The placebo subjects will then exit participation in the efficacy portion of the trial, and be followed for safety for 7 days. Treatment group subjects who do not feel pain after Von Frey testing will receive their surgery or diagnostic procedure and also be followed for safety for 7 days.

In the Safety second phase, subjects will be randomized in a 1:1 fashion to one of the two treatment groups (Cocaine HCl 4% or 10% topical solution) pre-procedure and given one application of up to one 4 mL of the assigned test product. After pre-procedure Von Frey filament testing reveals a pain score of 0, subjects will receive their surgery or diagnostic procedure, and then all subjects will be followed for safety for 7 days. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01746940
Study type Interventional
Source Lannett Company, Inc.
Contact
Status Terminated
Phase Phase 3
Start date March 2014
Completion date July 2015

See also
  Status Clinical Trial Phase
Recruiting NCT06111963 - Role of Inflammatory Markers in Sepsis
Recruiting NCT03779347 - Schistosomiasis Diagnosis Using a CAA Antigen Test Phase 3
Not yet recruiting NCT04800042 - Study of the Prevalence of Iron Deficiency in Patients With Scheduled Major Surgery (CARENFER PBM) N/A
Completed NCT05076188 - PARamedical Abnormalties Detection of Traumatic Bone Lesion of the extremitIeS
Completed NCT03832608 - Sarcopenia Cut-points and Functionality in Older Adults
Recruiting NCT06233539 - A Study on Diagnosis and Treatment Strategies for Atlantoaxial Dislocation
Completed NCT03250884 - Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.
Not yet recruiting NCT03495570 - Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral Infections